Fund Management at Engine No 1’s AbbVie ABBV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q4
Sell
-25,243
Closed -$3.76M 3
2023
Q3
$3.76M Buy
25,243
+2,274
+10% +$334K 0.58% 32
2023
Q2
$3.09M Buy
22,969
+1,520
+7% +$223K 0.57% 37
2023
Q1
$3.42M Buy
21,449
+1,980
+10% +$303K 0.69% 32
2022
Q4
$3.15M Buy
19,469
+2,468
+15% +$378K 0.77% 33
2022
Q3
$2.28M Sell
17,001
-842
-5% -$121K 0.67% 35
2022
Q2
$2.73M Buy
17,843
+2,876
+19% +$439K 0.72% 32
2022
Q1
$2.43M Buy
+14,967
New +$2.17M 0.61% 38

Other funds holding ABBV

Fund Management at Engine No 1's ABBV Position: Q4 2023 in Review

Fund Management at Engine No 1 sold out of AbbVie (ABBV) in Q4 2023, closing a stake of 25,243 shares — an estimated $3.76M sold.

Fund Management at Engine No 1 first reported a position in ABBV in Q1 2022 and held it in 7 quarters. The position peaked at $3.76M in Q3 2023. 3,322 funds tracked by Wall St. Rank hold ABBV as of Q4 2023.

  • Fund Management at Engine No 1 reported no remaining AbbVie position as of Q4 2023 after selling out during the quarter.
  • Fund Management at Engine No 1 sold 25,243 AbbVie shares in Q4 2023, an estimated $3.76M.
  • Fund Management at Engine No 1 first reported a position in AbbVie in Q1 2022 and held it in 7 quarters.
  • Fund Management at Engine No 1's AbbVie position peaked at $3.76M in Q3 2023.
  • 3,322 funds tracked by Wall St. Rank held AbbVie as of Q4 2023.

Based on Fund Management at Engine No 1's 13F filing for Q4 2023.